The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Devices Market Research Report 2025
Synopsis
Diabetes Devices adopts the method of data collection and analysis of diabetes care for patients with diabetes make reasonable prediction and control of diseases.
The global Diabetes Devices market was valued at US$ 21150 million in 2023 and is anticipated to reach US$ 33470 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Diabetes Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices.
Report Scope
The Diabetes Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Sanofi
Bayer
Becton
Dickinson and Company
Novo Nordisk
Abbott Laboratories
Roche
Lifescan
B. Braun
Dexcom
Ypsomed Holdings
Segment by Type
Blood Glucose Monitoring (BGM) Devices
Insulin Delivery Devices
Segment by Application
Hospital
Personal Use
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diabetes Devices adopts the method of data collection and analysis of diabetes care for patients with diabetes make reasonable prediction and control of diseases.
The global Diabetes Devices market was valued at US$ 21150 million in 2023 and is anticipated to reach US$ 33470 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Diabetes Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices.
Report Scope
The Diabetes Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Sanofi
Bayer
Becton
Dickinson and Company
Novo Nordisk
Abbott Laboratories
Roche
Lifescan
B. Braun
Dexcom
Ypsomed Holdings
Segment by Type
Blood Glucose Monitoring (BGM) Devices
Insulin Delivery Devices
Segment by Application
Hospital
Personal Use
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetes Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetes Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diabetes Devices Market Overview
1.1 Product Overview and Scope of Diabetes Devices
1.2 Diabetes Devices Segment by Type
1.2.1 Global Diabetes Devices Market Value Comparison by Type (2024-2030)
1.2.2 Blood Glucose Monitoring (BGM) Devices
1.2.3 Insulin Delivery Devices
1.3 Diabetes Devices Segment by Application
1.3.1 Global Diabetes Devices Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Personal Use
1.3.4 Clinic
1.3.5 Others
1.4 Global Diabetes Devices Market Size Estimates and Forecasts
1.4.1 Global Diabetes Devices Revenue 2019-2030
1.4.2 Global Diabetes Devices Sales 2019-2030
1.4.3 Global Diabetes Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetes Devices Market Competition by Manufacturers
2.1 Global Diabetes Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetes Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetes Devices Average Price by Manufacturers (2019-2024)
2.4 Global Diabetes Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetes Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetes Devices, Product Type & Application
2.7 Diabetes Devices Market Competitive Situation and Trends
2.7.1 Diabetes Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetes Devices Players Market Share by Revenue
2.7.3 Global Diabetes Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Devices Retrospective Market Scenario by Region
3.1 Global Diabetes Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetes Devices Global Diabetes Devices Sales by Region: 2019-2030
3.2.1 Global Diabetes Devices Sales by Region: 2019-2024
3.2.2 Global Diabetes Devices Sales by Region: 2025-2030
3.3 Global Diabetes Devices Global Diabetes Devices Revenue by Region: 2019-2030
3.3.1 Global Diabetes Devices Revenue by Region: 2019-2024
3.3.2 Global Diabetes Devices Revenue by Region: 2025-2030
3.4 North America Diabetes Devices Market Facts & Figures by Country
3.4.1 North America Diabetes Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetes Devices Sales by Country (2019-2030)
3.4.3 North America Diabetes Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetes Devices Market Facts & Figures by Country
3.5.1 Europe Diabetes Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetes Devices Sales by Country (2019-2030)
3.5.3 Europe Diabetes Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetes Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetes Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetes Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetes Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetes Devices Market Facts & Figures by Country
3.7.1 Latin America Diabetes Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetes Devices Sales by Country (2019-2030)
3.7.3 Latin America Diabetes Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetes Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetes Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetes Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetes Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diabetes Devices Sales by Type (2019-2030)
4.1.1 Global Diabetes Devices Sales by Type (2019-2024)
4.1.2 Global Diabetes Devices Sales by Type (2025-2030)
4.1.3 Global Diabetes Devices Sales Market Share by Type (2019-2030)
4.2 Global Diabetes Devices Revenue by Type (2019-2030)
4.2.1 Global Diabetes Devices Revenue by Type (2019-2024)
4.2.2 Global Diabetes Devices Revenue by Type (2025-2030)
4.2.3 Global Diabetes Devices Revenue Market Share by Type (2019-2030)
4.3 Global Diabetes Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetes Devices Sales by Application (2019-2030)
5.1.1 Global Diabetes Devices Sales by Application (2019-2024)
5.1.2 Global Diabetes Devices Sales by Application (2025-2030)
5.1.3 Global Diabetes Devices Sales Market Share by Application (2019-2030)
5.2 Global Diabetes Devices Revenue by Application (2019-2030)
5.2.1 Global Diabetes Devices Revenue by Application (2019-2024)
5.2.2 Global Diabetes Devices Revenue by Application (2025-2030)
5.2.3 Global Diabetes Devices Revenue Market Share by Application (2019-2030)
5.3 Global Diabetes Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Diabetes Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Diabetes Devices Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Diabetes Devices Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Becton
6.4.1 Becton Corporation Information
6.4.2 Becton Description and Business Overview
6.4.3 Becton Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Becton Diabetes Devices Product Portfolio
6.4.5 Becton Recent Developments/Updates
6.5 Dickinson and Company
6.5.1 Dickinson and Company Corporation Information
6.5.2 Dickinson and Company Description and Business Overview
6.5.3 Dickinson and Company Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dickinson and Company Diabetes Devices Product Portfolio
6.5.5 Dickinson and Company Recent Developments/Updates
6.6 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novo Nordisk Diabetes Devices Product Portfolio
6.6.5 Novo Nordisk Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Diabetes Devices Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Diabetes Devices Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Lifescan
6.9.1 Lifescan Corporation Information
6.9.2 Lifescan Description and Business Overview
6.9.3 Lifescan Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lifescan Diabetes Devices Product Portfolio
6.9.5 Lifescan Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Corporation Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 B. Braun Diabetes Devices Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Dexcom
6.11.1 Dexcom Corporation Information
6.11.2 Dexcom Diabetes Devices Description and Business Overview
6.11.3 Dexcom Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dexcom Diabetes Devices Product Portfolio
6.11.5 Dexcom Recent Developments/Updates
6.12 Ypsomed Holdings
6.12.1 Ypsomed Holdings Corporation Information
6.12.2 Ypsomed Holdings Diabetes Devices Description and Business Overview
6.12.3 Ypsomed Holdings Diabetes Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ypsomed Holdings Diabetes Devices Product Portfolio
6.12.5 Ypsomed Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetes Devices Industry Chain Analysis
7.2 Diabetes Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetes Devices Production Mode & Process
7.4 Diabetes Devices Sales and Marketing
7.4.1 Diabetes Devices Sales Channels
7.4.2 Diabetes Devices Distributors
7.5 Diabetes Devices Customers
8 Diabetes Devices Market Dynamics
8.1 Diabetes Devices Industry Trends
8.2 Diabetes Devices Market Drivers
8.3 Diabetes Devices Market Challenges
8.4 Diabetes Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
